Shinya Yamamoto

Summary

Affiliation: Cancer Institute Hospital
Country: Japan

Publications

  1. ncbi request reprint Longitudinal change in health-related quality of life after intensity-modulated radiation monotherapy for clinically localized prostate cancer
    Shinya Yamamoto
    Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3 8 31, Ariake, Tokyo, Koto ku, 135 8550, Japan
    Qual Life Res 23:1641-50. 2014
  2. doi request reprint Long-term oncological outcome and risk stratification in men with high-risk prostate cancer treated with radical prostatectomy
    Shinya Yamamoto
    Department of Urology, Cancer Institute Hospital, 3 8 31 Ariake, Koto ku, Tokyo, Japan
    Jpn J Clin Oncol 42:541-7. 2012
  3. doi request reprint Feasibility of antegrade radical prostatectomy for clinically locally advanced prostate cancer: a comparative study with clinically localized disease
    Shinya Yamamoto
    Department of Urology, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan
    Int J Urol 17:720-5. 2010
  4. doi request reprint Prognostic significance of cancer volume involving seminal vesicles in patients with pT3bpN0 prostate cancer
    Shinya Yamamoto
    Department of Urology, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan
    Urology 72:1224-8. 2008
  5. ncbi request reprint Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy
    Shinya Yamamoto
    Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
    Eur Urol 52:696-701. 2007
  6. doi request reprint Risk stratification of high-grade prostate cancer treated with antegrade radical prostatectomy with intended wide resection
    Shinya Yamamoto
    Department of Urology, Japanese Foundation for Cancer Research, Cancer Institute Hospital, 3 10 6 Ariake, Koto ku, Tokyo 135 8550, Japan
    Jpn J Clin Oncol 39:387-93. 2009
  7. ncbi request reprint Transperineal ultrasound-guided 12-core systematic biopsy of the prostate for patients with a prostate-specific antigen level of 2.5-20 ng/ml in Japan
    Shinya Yamamoto
    Department of Urology, Cancer Institute Hospital, 3 10 6 Ariake, Tokyo 135 8550, Japan
    Int J Clin Oncol 10:117-21. 2005
  8. ncbi request reprint Possibility of recovery of estrogen sensitivity following high-dose glucocorticoid therapy in a patient with hormone-refractory prostate cancer
    Shinya Yamamoto
    Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3 10 6 Ariake, Koto ku, Tokyo 135 8550, Japan
    Int J Clin Oncol 11:326-8. 2006
  9. doi request reprint Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy
    Satoru Kawakami
    Department of Urology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan
    Eur Urol 54:601-11. 2008
  10. doi request reprint Lymphovascular invasion is an independent predictor of prostate-specific antigen failure after radical prostatectomy in patients with pT3aN0 prostate cancer
    Shinya Yamamoto
    Department of Urology, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan
    Int J Urol 15:895-9. 2008

Detail Information

Publications46

  1. ncbi request reprint Longitudinal change in health-related quality of life after intensity-modulated radiation monotherapy for clinically localized prostate cancer
    Shinya Yamamoto
    Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3 8 31, Ariake, Tokyo, Koto ku, 135 8550, Japan
    Qual Life Res 23:1641-50. 2014
    ....
  2. doi request reprint Long-term oncological outcome and risk stratification in men with high-risk prostate cancer treated with radical prostatectomy
    Shinya Yamamoto
    Department of Urology, Cancer Institute Hospital, 3 8 31 Ariake, Koto ku, Tokyo, Japan
    Jpn J Clin Oncol 42:541-7. 2012
    ..To evaluate the long-term oncological outcome of radical prostatectomy for patients with high-risk prostate cancer...
  3. doi request reprint Feasibility of antegrade radical prostatectomy for clinically locally advanced prostate cancer: a comparative study with clinically localized disease
    Shinya Yamamoto
    Department of Urology, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan
    Int J Urol 17:720-5. 2010
    ....
  4. doi request reprint Prognostic significance of cancer volume involving seminal vesicles in patients with pT3bpN0 prostate cancer
    Shinya Yamamoto
    Department of Urology, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan
    Urology 72:1224-8. 2008
    ..To investigate the prognostic effect of the prostate cancer (PCa) volume involving the seminal vesicles (CVSVs) in the radical prostatectomy specimen from patients with Stage pT3bpN0 PCa...
  5. ncbi request reprint Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy
    Shinya Yamamoto
    Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
    Eur Urol 52:696-701. 2007
    ..The aim of this study was to investigate the relationship between preoperative TS and prostate-specific antigen (PSA) failure in these patients...
  6. doi request reprint Risk stratification of high-grade prostate cancer treated with antegrade radical prostatectomy with intended wide resection
    Shinya Yamamoto
    Department of Urology, Japanese Foundation for Cancer Research, Cancer Institute Hospital, 3 10 6 Ariake, Koto ku, Tokyo 135 8550, Japan
    Jpn J Clin Oncol 39:387-93. 2009
    ..The aim of this study was to assess the surgical outcome of high-grade prostate cancer (PCA) treated with antegrade radical prostatectomy with intended wide resection (aRP) and to establish the risk stratification...
  7. ncbi request reprint Transperineal ultrasound-guided 12-core systematic biopsy of the prostate for patients with a prostate-specific antigen level of 2.5-20 ng/ml in Japan
    Shinya Yamamoto
    Department of Urology, Cancer Institute Hospital, 3 10 6 Ariake, Tokyo 135 8550, Japan
    Int J Clin Oncol 10:117-21. 2005
    ..The aim of this study was to investigate the cancer detection rate in patients with a prostate-specific antigen (PSA) level of 2.5 to 20 ng/ml, using transperineal ultrasound-guided systematic biopsy of the prostate...
  8. ncbi request reprint Possibility of recovery of estrogen sensitivity following high-dose glucocorticoid therapy in a patient with hormone-refractory prostate cancer
    Shinya Yamamoto
    Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3 10 6 Ariake, Koto ku, Tokyo 135 8550, Japan
    Int J Clin Oncol 11:326-8. 2006
    ..No optimal therapy has yet been established for HRPCA; therefore, high-dose glucocorticoid therapy in combination with DES-DP warrants further study...
  9. doi request reprint Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy
    Satoru Kawakami
    Department of Urology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan
    Eur Urol 54:601-11. 2008
    ..Using cohorts examined by extended biopsy, we developed and validated multivariate models predicting prostate cancer on initial biopsy and examined whether these extended biopsy-based models outperform previously established models...
  10. doi request reprint Lymphovascular invasion is an independent predictor of prostate-specific antigen failure after radical prostatectomy in patients with pT3aN0 prostate cancer
    Shinya Yamamoto
    Department of Urology, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan
    Int J Urol 15:895-9. 2008
    ..To investigate the association of lymphovascular invasion (LVI) in radical prostatectomy (RP) specimens with prostate-specific antigen (PSA) failure in patients with pT3aN0 prostate cancer (PCA)...
  11. doi request reprint Clinical efficacy and prognostic factors for overall survival in Japanese patients with metastatic renal cell cancer treated with sunitinib
    Takeshi Yuasa
    Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan
    BJU Int 109:1349-54. 2012
    ..The application of the MSKCC model distinctly separated OS curves (P<0.001), suggesting that MSKCC prognostic factors might be still valid to predict survival in metastatic RCC in the era of molecular targeted therapy...
  12. doi request reprint Preliminary report of multimodal treatment with ifosfamide, 5-fluorouracil, etoposide and cisplatin (IFEP chemotherapy) against metastatic adenocarcinoma of the urachus
    Manabu Tatokoro
    Department of Urology, Cancer Institute Hospital, Tokyo, Japan
    Int J Urol 15:851-3. 2008
    ..A multimodal treatment strategy, even with curative intent, can be considered when a sufficient effect was obtained by the IFEP chemotherapy...
  13. ncbi request reprint Prognostic impact of pretreatment C-reactive protein for patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors
    Yosuke Yasuda
    Department of Urology, Cancer Institute Hospital of Japanese Foundation For Cancer Research, 3 8 31 Ariake, Koto ku, Tokyo, 135 8550, Japan
    Int J Clin Oncol 18:884-9. 2013
    ..Therefore, we further evaluated the prognostic impact of CRP for patients with metastatic renal cell carcinoma treated with molecular-targeted agents of tyrosine kinase inhibitors...
  14. doi request reprint Impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma treated by second-line chemotherapy with gemcitabine, etoposide and cisplatin
    Kazutaka Saito
    Department of Urology, Cancer Institute Hospital, Japanese Foundation of Cancer Research, Tokyo, Japan
    BJU Int 110:1478-84. 2012
    ....
  15. doi request reprint Prognostic impact of C-reactive protein for determining overall survival of patients with castration-resistant prostate cancer treated with docetaxel
    Masaya Ito
    Department of Urology, Cancer Institute Hospital, Japanese Foundation of Cancer Research, Tokyo, Japan
    Urology 78:1131-5. 2011
    ..To verify the prognostic impact of C-reactive protein (CRP) for patients with castration-resistant prostate cancer (CRPC) treated with docetaxel in a single institution...
  16. ncbi request reprint Possible improvement of survival with use of zoledronic acid in patients with bone metastases from renal cell carcinoma
    Yosuke Yasuda
    Department of Urology, Cancer Institute Hospital of Japanese Foundation For Cancer Research, 3 8 31, Ariake, Koto ku, Tokyo, 135 8550, Japan
    Int J Clin Oncol 18:877-83. 2013
    ..However, it remains unclear whether bisphosphonates improve overall survival (OS) for renal cell carcinoma (RCC) patients with bone metastases...
  17. doi request reprint Body mass index influences prostate cancer risk at biopsy in Japanese men
    Hitoshi Masuda
    Department of Urology, Graduate School of Tokyo Medical and Dental University, Tokyo, Japan
    Int J Urol 20:701-7. 2013
    ..To determine the relationship between body mass index and prostate cancer risk at biopsy in Japanese men, and to compared the risk with that of Caucasian men...
  18. doi request reprint Extended biopsy based criteria incorporating cumulative cancer length for predicting clinically insignificant prostate cancer
    Yoshinobu Komai
    Department of Urology, Tokyo Medical and Dental University Graduate, Tokyo, Japan
    BJU Int 110:E564-9. 2012
    ..The present study has added new criteria for predicting insignificant prostate cancer, which would lead to a better selection of candidates for AS...
  19. doi request reprint History of malignancy is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram
    Satoru Kawakami
    Department of Urology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan
    Int J Urol 15:1055-60. 2008
    ....
  20. doi request reprint Diagnostic performance of initial transperineal 14-core prostate biopsy to detect significant cancer
    Hideki Takeshita
    Department of Urology, Tokyo Medical and Dental University Graduate School, 1 5 45 Yushima, Bunkyo ku, Tokyo, 113 8519, Japan
    Int Urol Nephrol 45:645-52. 2013
    ..To investigate cancers missed by extended transperineal (TP) 14-core biopsy (TP14PBx) and examined its diagnostic performance...
  21. pmc Early onset recall pneumonitis during targeted therapy with sunitinib
    Takeshi Yuasa
    Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, 135 8550, Japan
    BMC Cancer 13:3. 2013
    ..Sunitinib interacts with radiation therapy, leading to synergism of the toxicities of these treatments. Radiation recall pneumonitis is a rare but serious complication of targeted therapy with tyrosine kinase inhibitors...
  22. doi request reprint Evaluation of the RENAL nephrometry scoring system in adopting nephron-sparing surgery for cT1 renal cancer
    Yosuke Yasuda
    Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan yosukey17 yahoo co jp
    Urol Int 90:179-83. 2013
    ..The current study aims to evaluate the RENAL nephrometry scoring system in adopting nephron-sparing surgery (NSS) for cT1 renal cancer...
  23. doi request reprint Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL
    Hiroshi Fukushima
    Department of Urology, Tokyo Medical and Dental University, Graduate School, Tokyo, Japan
    Urology 79:1329-34. 2012
    ..To investigate the association of diabetes mellitus (DM) with prostate cancer (PCa) risk and grade among Japanese patients undergoing extended biopsy and to investigate how obesity modifies these relationships...
  24. doi request reprint Treatment outcome and prognostic factors in renal cell cancer patients with bone metastasis
    Takeshi Yuasa
    Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Koto ku, Tokyo, Japan
    Clin Exp Metastasis 28:405-11. 2011
    ..In this population, MSKCC scores were valid predictors of survival. With increased treatment options, RCC patients with bone metastasis may benefit further from subsequent modalities and/or agents...
  25. ncbi request reprint Antegrade radical retropubic prostatectomy with preliminary ligation of vascular pedicles in 614 consecutive patients
    Satoru Kawakami
    Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
    Jpn J Clin Oncol 37:528-33. 2007
    ....
  26. doi request reprint The processus vaginalis transection method to prevent postradical prostatectomy inguinal hernia: long-term results
    Yasuhisa Fujii
    Department of Urology, Cancer Institute Hospital of Japanese Foundation For Cancer Research, Koto ku, Tokyo, Japan Department of Urology, Tokyo Medical and Dental University Graduate School, Bunkyo ku, Tokyo, Japan Electronic address
    Urology 83:247-52. 2014
    ..To evaluate the long-term effect of the processus vaginalis transection method, which we previously developed to prevent postradical prostatectomy inguinal hernia...
  27. doi request reprint Equivalent and sufficient effects of leuprolide acetate and goserelin acetate to suppress serum testosterone levels in patients with prostate cancer
    Yasuhisa Fujii
    Department of Urology, Cancer Institute Hospital, Japanese Foundation of Cancer Research, Tokyo, Japan
    BJU Int 101:1096-100. 2008
    ....
  28. ncbi request reprint Successful 2-year-long remission following repeated salvage surgery in a patient with chemotherapy-resistant metastatic nonseminomatous germ cell tumor
    Hideki Takeshita
    Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
    Int J Clin Oncol 12:485-7. 2007
    ..The present case suggests that repeated salvage surgery may be beneficial in selected patients with a chemotherapy-resistant metastatic germ cell tumor...
  29. doi request reprint Characteristics and clinical significance of prostate cancers missed by initial transrectal 12-core biopsy
    Noboru Numao
    Department of Urology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan
    BJU Int 109:665-71. 2012
    ..To characterize prostate cancers missed by initial transrectal 12-core biopsy...
  30. ncbi request reprint [Significance of ipsilateral adrenalectomy in surgery for renal cell carcinoma]
    Yoshinobu Komai
    Department of Urology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research
    Nihon Hinyokika Gakkai Zasshi 101:592-6. 2010
    ..The aim of this study is to analyze the incidence of involvement of ipsilateral adrenal gland from renal cell carcinoma and assess the actual significance of ipsilateral adrenalectomy at nephrectomy...
  31. doi request reprint Combination chemotherapy of ifosfamide, 5-fluorouracil, etoposide and cisplatin as perioperative treatment in lymph node positive bladder carcinoma patients treated by radical cystectomy
    Yoshinobu Komai
    Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
    Int J Urol 15:971-5. 2008
    ..To evaluate the efficacy and toxicity of perioperative combination chemotherapy with ifosfamide, 5-fluorouracil, etoposide and cisplatin (IFEP) in bladder cancer patients with regional lymph node metastases treated by radical cystectomy...
  32. doi request reprint Impact of lower urinary tract symptoms on prostate cancer risk among Japanese men with prostate-specific antigen <10 ng/mL and non-suspicious digital rectal examination
    Masaya Ito
    Department of Urology, Graduate School of Tokyo Medical and Dental University, Tokyo, Japan
    Int J Urol 20:1163-8. 2013
    ..To investigate the association between lower urinary tract symptoms status and prostate cancer risk at initial extended biopsy...
  33. ncbi request reprint Direct comparison between transrectal and transperineal extended prostate biopsy for the detection of cancer
    Satoru Kawakami
    Department of Urology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan
    Int J Urol 14:719-24. 2007
    ..To establish whether extended transrectal (TR) and extended transperineal (TP) biopsies are equivalent in detecting prostate cancer...
  34. doi request reprint Diverse fusion patterns and heterogeneous clinicopathologic features of renal cell carcinoma with t(6;11) translocation
    Kentaro Inamura
    Division of Pathology, The Cancer Institute, The Cancer Institute Hospital, Tokyo, Japan
    Am J Surg Pathol 36:35-42. 2012
    ..Our study will contribute to the correct diagnosis of TFEB RCC...
  35. doi request reprint A novel technique to prevent postradical retropubic prostatectomy inguinal hernia: the processus vaginalis transection method
    Yasuhisa Fujii
    Department of Urology, Cancer Institute Hospital, Japanese Foundation of Cancer Research, Tokyo, Japan
    Urology 75:713-7. 2010
    ..The incidence of inguinal hernia after RRP has been reported to occur in the range 12%-21%. Indirect hernias are more common than direct hernias after RRP...
  36. doi request reprint Outcome of antegrade radical prostatectomy with intended wide resection in prostate cancer patients with a preoperative serum PSA level >100 ng/ml
    Shinji Urakami
    Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
    Urol Int 87:175-81. 2011
    ..It was the aim of this study to assess the outcome of prostate cancer patients with preoperative prostate-specific antigen (PSA) levels ≥100 ng/ml who were treated with antegrade radical prostatectomy with intended wide resection (aRP)...
  37. doi request reprint Phase II trial of first-line chemotherapy with gemcitabine, etoposide, and cisplatin for patients with advanced urothelial carcinoma
    Shinji Urakami
    Department of Urology, Cancer Institute Hospital, Japanese Foundation of Cancer Research, Tokyo, Japan Electronic address
    Urol Oncol 32:35.e1-7. 2014
    ..This study sought to examine the combination chemotherapy of gemcitabine, etoposide, and cisplatin (GEP) as a first-line treatment for advanced urothelial carcinoma (UC) to assess its antitumor activity and toxicity...
  38. doi request reprint Radiotherapy to bone metastases from renal cell carcinoma with or without zoledronate
    Toshiki Kijima
    Department of Urology, Cancer Institute Hospital, Japanese Foundation of Cancer Research, Tokyo, Japan
    BJU Int 103:620-4. 2009
    ..To investigate the rate of objective response and the skeletal-related event (SRE)-free survival after combined therapy with radiotherapy (RT) and zoledronate in patients with bone metastases from renal cell carcinoma (RCC)...
  39. doi request reprint A novel repeat biopsy nomogram based on three-dimensional extended biopsy
    Mizuaki Sakura
    Department of Urology, Tokyo Medical and Dental University, Graduate School, Tokyo, Japan
    Urology 77:915-20. 2011
    ..To develop a nomogram based on a cohort examined with 3-dimensional (3D) protocol for diagnosis of prostate cancer on repeat biopsy...
  40. doi request reprint Tumor size is a potential predictor of response to tyrosine kinase inhibitors in renal cell cancer
    Takeshi Yuasa
    Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan
    Urology 77:831-5. 2011
    ..To select the patients who can benefit the most from treatment with targeted agents, it will be necessary to find a tumor characteristic that predicts their effectiveness...
  41. doi request reprint Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry
    Yoshinobu Komai
    Department of Urology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan
    Clin Cancer Res 15:1170-6. 2009
    ..To determine the incidence of Xp11 translocation renal cell carcinoma (RCC) in adult patients using cytogenetics and immunohistochemstry...
  42. ncbi request reprint The possibility of 'de novo' cancer in the prostate
    Shinya Yamamoto
    Department of Urology, Tokyo Medical University, Tokyo, Japan
    Int J Urol 12:361-4. 2005
    ..To investigate the possibility of 'de novo' prostate cancer by analyzing the relationship between high grade prostatic intraepithelial neoplasia (HGPIN) and latent prostate cancer...
  43. doi request reprint Relationship between bone mineral density and androgen-deprivation therapy in Japanese prostate cancer patients
    Takeshi Yuasa
    Department of Medical Oncology and Genitourinary Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
    Urology 75:1131-7. 2010
    ..However, our previous cross-sectional study revealed that short-term ADT (average, 23.5 months) does not significantly increase the prevalence of osteoporosis in Japanese patients...
  44. pmc Denosumab: a new option in the treatment of bone metastases from urological cancers
    Takeshi Yuasa
    Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan
    Onco Targets Ther 5:221-9. 2012
    ..Denosumab is emerging as a key therapeutic option in the treatment of bone metastases from urological cancers...
  45. ncbi request reprint Does transrectal ultrasound guided eight-core prostate biopsy improve cancer detection rates in patients with prostate-specific antigen levels of 4.1-10 ng/mL?
    Shinya Yamamoto
    Department of Urology, Chiba Cancer Center, Chiba, Japan
    Int J Urol 11:386-91. 2004
    ..To investigate retrospectively whether the eight-core biopsy method improves the prostate cancer detection rate when compared with the standard sextant biopsy method in patients with prostate specific antigen (PSA) levels of 4.1-10 ng/mL...
  46. ncbi request reprint [IGF-1, IGFBP-3, PICP, ICTP]
    Takaaki Ito
    Department of Urology, Tokyo Medical University
    Nihon Rinsho 60:156-9. 2002